Scienture Holdings, Inc.
SCNX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001382574
No open-market purchases or sales by Scienture Holdings, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $709.1K in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Scienture Holdings, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 12
- −3 vs. Q4 2022
- Shares held
- 236.4K
- −692.5K (−74.5%) vs. Q4 2022
- Total value
- $69.2K
- −$306.8K (−81.6%) vs. Q4 2022
- New holders
- 3
- 2 more added
- Sold out
- 6
- 3 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SCNX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 15 | $709.1K |
| Q1 2026 | 13 | $405.1K |
| Q4 2025 | 12 | $693.6K |
| Q3 2025 | 11 | $381.8K |
| Q2 2025 | 8 | $111.9K |
| Q1 2025 | 9 | $160.1K |
| Q4 2024 | 9 | $566.7K |
| Q3 2024 | 7 | $301.5K |
| Q2 2024 | 6 | $395.7K |
| Q1 2024 | 9 | $805.3K |
| Q4 2023 | 6 | $14.5K |
| Q3 2023 | 6 | $14.2K |
| Q2 2023 | 8 | $298.2K |
| Q1 2023 | 12 | $69.2K |
| Q4 2022 | 15 | $376.0K |
| Q3 2022 | 13 | $658.0K |
| Q2 2022 | 13 | $953.0K |
| Q1 2022 | 13 | $1.49M |
| Q4 2021 | 15 | $1.52M |
| Q3 2021 | 11 | $2.60M |
| Q2 2021 | 12 | $2.25M |
| Q1 2021 | 15 | $5.83M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Scienture Holdings, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| National Asset Management, Inc. | 48,278 | $14.2K | 0.00% | −23,375−32.6% | Reduced |
| Geode Capital Management, LLC | 42,057 | $12.4K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 39,629 | $11.7K | 0.00% | −119,112−75.0% | Reduced |
| Wealth Dimensions Group, Ltd. | 30,979 | $9.14K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 25,111 | $7.00K | 0.00% | +25,111 | New |
| Susquehanna International Group, LLP | 19,580 | $5.78K | 0.00% | +19,580 | New |
| Tower Research Capital LLC (TRC) | 17,751 | $5.00K | 0.00% | +5,312+42.7% | Added |
| Ronald Blue Trust, Inc. | 5,354 | $2.00K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 4,169 | $1.23K | 0.00% | +4,169 | New |
| Spire Wealth Management | 2,458 | $738 | 0.00% | −58−2.3% | Reduced |
| Wells Fargo & Company | 31 | $9 | 0.00% | +1+3.3% | Added |
| Royal Bank of Canada | 1,000 | $0 | 0.00% | 00.0% | Unchanged |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −514,998−100.0% | Sold out |
| Ridgewood Investments LLC | 0 | $0 | 0.00% | −61,896−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −11,315−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −11,491−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −4,395−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −4−100.0% | Sold out |